Details of the Drug

General Information of Drug (ID: DMWX5Q6)

• Drug Name: Propan-2-one O-4-propoxyphenylcarbamoyl oxime
• Synonyms: CHEMBL609315; propan-2-one O-4-propoxyphenylcarbamoyl oxime

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 250.29
  Logarithm of the Partition Coefficient (xlogp); 2.6
  Rotatable Bond Count (rotbonds); 6
  Hydrogen Bond Donor Count (hbonddonor); 1
  Hydrogen Bond Acceptor Count (hbondacc); 4
• Chemical Identifiers:
  Formula: C13H18N2O3
  IUPAC Name: (propan-2-ylideneamino) N-(4-propoxyphenyl)carbamate
  Canonical SMILES: CCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C
  InChI: InChI=1S/C13H18N2O3/c1-4-9-17-12-7-5-11(6-8-12)14-13(16)18-15-10(2)3/h5-8H,4,9H2,1-3H3,(H,14,16)
  InChIKey: DAVIGWYJZIPGFN-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 20872824
  TTD ID: D07BGB

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Fatty acid amide hydrolase (FAAH)	TTDP1UC	NOUNIPROTAC	Inhibitor	[1]

Molecular Expression Atlas of This Drug

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Fatty acid amide hydrolase (FAAH)	DTT	NO-GeName	2.65E-01	0.02	0.1

References

• [1] Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7.